Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
Winston Salem, North Carolina, United States
Cancer treatment center in Winston-Salem, North Carolina
1010 Bethesda Court, Winston-Salem, NC 27103
About Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
During the past decade, Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-03-08
2022-08-12
Completed
1,301
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
2017-12-11
2021-02-19
Terminated
446
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates"
#1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
According to Clinical.Site data, the most researched conditions in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" are
"Advanced BRAFV600 Wild-type Melanoma" (1 trials), "B-cell Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
Most popular intervention types in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Rituximab" (2 trials), "Atezolizumab Placebo" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
The vast majority of trials in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
Currently, there are NaN active trials in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".